UK-based medical technology company ChestPal has launched its new digital stethoscope, ChestPal Pro, for healthcare practitioners in the US.

The introduction marks a significant advancement in diagnostic tools available in the market.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The device, which offers automatic detection and classification of crackles and wheezes, is designed to aid clinicians in making accurate and swift diagnoses, potentially reducing emergency room visits for respiratory conditions.

ChestPal Pro’s technology converts lung sounds into visual spectrograms, enhancing the accuracy and reliability of lung sound analysis across various types.

This feature is particularly beneficial for the diagnosis and management of life-threatening respiratory diseases such as pneumonia, asthma, and chronic obstructive pulmonary disease.

The device also simplifies the process of recording, monitoring, and transmitting lung sounds, streamlining patient care.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Its lung exam-sharing capability is especially useful for case escalation and referrals, providing convenience for healthcare providers and patients, especially when specialists are not close to the patient.

ChestPal co-founder and chief product officer Helena Binetskaya said: “We created ChestPal Pro to make lung sound classification more objective and reliable for frontline healthcare professionals as part of their clinical decision-making process.”

According to a recent Glimpse survey, 60% of healthcare practitioners reported sending respiratory patients to the emergency room when lung sounds could not be accurately detected.

Furthermore, 85% believe that a smart stethoscope capable of detecting subtle lung sounds could play a significant role in reducing ER visits.

Northwestern Medicine general internal medicine physician Dr Emily Tuchman said: “ChestPal Pro helps pick up lung sounds that are too subtle to hear when using a stethoscope alone.

“I listened to a patient’s lungs with my stethoscope and didn’t auscultate wheezing, but with ChestPal Pro, I picked up wheezing and could prescribe the steroids and inhaler my patient needed to improve.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact